Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Colorcon
Boehringer Ingelheim
Medtronic
Express Scripts

Last Updated: November 26, 2022

CLINICAL TRIALS PROFILE FOR VALDECOXIB


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Valdecoxib

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00021996 ↗ Valdecoxib in Treating Chronic Pain in Cancer Patients Completed Dana-Farber Cancer Institute N/A 2001-01-01 RATIONALE: Valdecoxib may be effective in relieving chronic pain in cancer patients. It is not yet known if valdecoxib is effective in treating chronic pain. PURPOSE: Randomized clinical trial to study the effectiveness of valdecoxib in relieving chronic pain in cancer patients.
NCT00092300 ↗ A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2002-05-01 The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.
NCT00092339 ↗ A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2002-08-01 The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Valdecoxib

Condition Name

Condition Name for Valdecoxib
Intervention Trials
Pain 10
Osteoarthritis 2
Postoperative Pain 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Valdecoxib
Intervention Trials
Pain, Postoperative 7
Sprains and Strains 3
Signs and Symptoms 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Valdecoxib

Trials by Country

Trials by Country for Valdecoxib
Location Trials
United States 114
Brazil 22
Canada 12
Colombia 11
Japan 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Valdecoxib
Location Trials
Pennsylvania 7
Arizona 6
Maryland 6
Texas 6
Florida 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Valdecoxib

Clinical Trial Phase

Clinical Trial Phase for Valdecoxib
Clinical Trial Phase Trials
Phase 4 13
Phase 3 11
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Valdecoxib
Clinical Trial Phase Trials
Completed 24
Terminated 4
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Valdecoxib

Sponsor Name

Sponsor Name for Valdecoxib
Sponsor Trials
Pfizer 20
Merck Sharp & Dohme Corp. 3
Fundação de Amparo à Pesquisa do Estado de São Paulo 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Valdecoxib
Sponsor Trials
Industry 23
Other 12
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
McKesson
Baxter
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.